Prescribing Information
Daniel Malson: System Owner
Allison McInerney: Business Owner
Supplier/Vendor host: DXC
Site Manager: Deana Lysy
United States Digital Labeling
Source URL for Web development
Posting Effective Date
(Internet/public domain posting date)
(Internet/public domain posting date)
Exception / Notes / Comments
https://www.pi.amgen.com/united_states/aimovig/Aimovig_pi_hcp_english.pdf
05/18/2023
PFS IFU is not marketed in the US at this time
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_70_hcp_pt_english.pdf
05/18/2023
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_140_english.pdf
05/18/2023
https://www.pi.amgen.com/united_states/aimovig/Aimovig_pi_hcp_spanish.pdf
11/29/2021
PFS IFU is not marketed in the US at this time
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_hcp_pt_spanish.pdf
11/29/2021
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ifu_140_spanish.pdf
11/29/2021
https://www.pi.amgen.com/united_states/aimovig/Aimovig_ppi_pt_spanish.pdf
11/29/2021
https://www.pi.amgen.com/united_states/aimovig70/Aimovig_rg_english.pdf
08/17/2022
https://www.pi.amgen.com/united_states/aimovig140/Aimovig_rg_english.pdf
08/17/2022
https://www.pi.amgen.com/united_states/amjevita/AMJEVITA_pi_hcp_english.pdf
10/30/2023
https://www.pi.amgen.com/united_states/amjevita/AMJEVITA_ppi_pt_english.pdf
10/30/2023
https://www.pi.amgen.com/united_states/amjevita/amjevita_sdvifu.pdf
08/01/2022
https://www.pi.amgen.com/united_states/amjevita/amjevita_pfsifu_10_english.pdf
05/17/2023
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_pi_hcp_english.pdf
02/05/2019
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_mg_hcp_english.pdf
12/21/2018
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_piu_pt_vial_english.pdf
05/31/2012
https://www.pi.amgen.com/united_states/aranesp/ckd/aranesp_piu_pt_singleject_english.pdf
04/27/2016
https://www.pi.amgen.com/united_states/avsola/avsola_pi_english.pdf
09/13/2021
https://www.pi.amgen.com/united_states/blincyto/blincyto_pi_hcp_english.pdf
06/21/2023
https://www.pi.amgen.com/united_states/blincyto/blincyto_mg_hcp_english.pdf
06/21/2023
https://www.pi.amgen.com/united_states/corlanor/corlanor_pi.pdf
08/12/2021
https://www.pi.amgen.com/united_states/corlanor/corlanor_pi_hcp.pdf
08/12/2021
https://www.pi.amgen.com/united_states/epogen/epogen_pi_hcp_english.pdf
07/25/2018
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_pi.pdf
10/20/2023
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_pi_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_mg.pdf
10/20/2023
https://www.pi.amgen.com/united_states/enbrel/derm/mg_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_piu.pdf
07/31/2023
https://www.pi.amgen.com/united_states/enbrel/derm/Combined_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_scifu.pdf
07/31/2023
https://www.pi.amgen.com/united_states/enbrel/derm/SCI_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_sdvifu.pdf
06/21/2022
https://www.pi.amgen.com/united_states/enbrel/derm/SDV_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_PFSIFU.pdf
07/31/2023
https://www.pi.amgen.com/united_states/enbrel/derm/PFS_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_MUVIFU.pdf
11/08/2019
https://www.pi.amgen.com/united_states/enbrel/derm/MUV_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_ATIFU.pdf
07/31/2023
https://www.pi.amgen.com/united_states/enbrel/derm/AT_IFU_spanish.pdf
11/29/2022
https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_user_manual_for_auto_touch_connect.pdf
07/31/2023
https://www.pi.amgen.com/united_states/evenity/evenity_pi.pdf
05/01/2020
https://www.pi.amgen.com/united_states/evenity/evenity_pi_hcp_english.pdf
05/01/2020
https://www.pi.amgen.com/united_states/imlygic/imlygic_pi.pdf
02/10/2023
https://www.pi.amgen.com/united_states/kanjinti/kanjinti_pi.pdf
10/17/2022
https://www.pi.amgen.com/united_states/kyprolis/kyprolis_pi.pdf
07/01/2022
https://www.pi.amgen.com/united_states/lumakras/lumakras_pi_hcp_english.pdf
04/25/2023
https://www.pi.amgen.com/united_states/lumakras/lumakras_ppi_pt_english.pdf
01/20/2023
https://www.pi.amgen.com/united_states/mvasi/MVASI_pi_hcp_english.pdf
02/20/2023
https://www.pi.amgen.com/united_states/neulasta/neulasta_pi_hcp_english.pdf
03/05/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_ppi_pt_english.pdf
01/14/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_ifu_hcp_pt_english.pdf
03/05/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_hcp_ifu_obi.pdf
03/05/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_patient_ifu_obi.pdf
01/04/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_hcp_ifu_obiQ32021.pdf
03/05/2021
https://www.pi.amgen.com/united_states/neulasta/neulasta_patient_ifu_obiQ32021.pdf
11/20/2020
https://www.pi.amgen.com/united_states/neupogen/neupogen_pi_hcp_english.pdf
04/19/2023
https://www.pi.amgen.com/united_states/neupogen/neupogen_ppi_pt_english.pdf
01/14/2021
https://www.pi.amgen.com/united_states/neupogen/neupogen_vial_ifu.pdf
06/29/2016
https://www.pi.amgen.com/united_states/nplate/nplate_pi_hcp_english.pdf
02/15/2022
https://www.pi.amgen.com/united_states/otezla/otezla_pi_english.pdf
07/24/2023
https://www.pi.amgen.com/united_states/prolia/prolia_pi.pdf
01/04/2023
https://www.pi.amgen.com/united_states/prolia/prolia_isi_combined.pdf
09/10/2020
Not labeling; exception for ISI to be digitally linked for REMS website ONLY. April 2020 label effective date
https://www.pi.amgen.com/united_states/prolia/prolia_pfs_temporary_self-admin_ifu.pdf
05/21/2020
For use per FDA only for the duration of the COVID-19 public health emergency declared by the Secretary of HHS on January 31, 2020. Effective 5-21-2020 in alignment with DHCP distribution
https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english.pdf
08/17/2022
PFS IFU is not marketed in the US at this time.
https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_spanish.pdf
01/09/2023
PFS is not Marketed at this time and was not translated for digital dissemination
https://www.pi.amgen.com/united_states/repatha/repatha_ppi_pt_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/repatha/repatha_ifu_hcp_pt_english.pdf
08/17/2022
https://www.pi.amgen.com/united_states/repatha/repatha_AI-IFU_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/repatha/repatha_pfs_ifu_hcp_pt_english.pdf
09/27/2021
PFS not marketed at this time
https://www.pi.amgen.com/united_states/repatha/repatha_obi_ifu_hcp_pt_english.pdf
09/27/2021
https://www.pi.amgen.com/united_states/repatha/repatha_OBI-IFU_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/repatha/repatha_rg_english.pdf
08/17/2022
https://www.pi.amgen.com/united_states/repatha/repatha_rg_spanish.pdf
01/09/2023
https://www.pi.amgen.com/united_states/riabni/riabni_pi_english.pdf
06/03/2022
https://www.pi.amgen.com/united_states/sensipar/sensipar_pi_hcp_english.pdf
12/06/2019
https://www.pi.amgen.com/united_states/Tavneos/tavneos_fpi_english.pdf
10/07/2021
https://www.pi.amgen.com/united_states/Tavneos/tanveos_mg_english.pdf
10/07/2021
https://www.pi.amgen.com/united_states/tezspire/tezspire_pi_hcp_english.pdf
05/26/2023
URL redirects to AZPI Central labeling
https://www.pi.amgen.com/united_states/tezspire/tezspire_ppi_pt_english.pdf
02/02/2023
URL redirects to AZPI Central labeling
https://www.pi.amgen.com/united_states/tezspire/tezspire_ifu_english.pdf
02/02/2023
URL redirects to AZPI Central labeling
https://www.pi.amgen.com/united_states/tezspire/tezspire_FPI_Spanish.pdf
03/03/2023
URL redirects to AZPI Central Labeling
https://www.pi.amgen.com/united_states/vectibix/vectibix_pi.pdf
08/30/2021
https://www.pi.amgen.com/united_states/xgeva/xgeva_pi.pdf
06/10/2020